Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | NG9E2 | — |
A female patient received an expired dose of Menveo; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number NG9E2, expiry date 30-JUN-2025) for prophylaxis. On 14-AUG-2025, the patient received Menveo. On 14-AUG-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: A female patient received an expired dose of Menveo). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 14-AUG-2025 The reporter reported that the administration of an expired dose of Menveo (1 vial) to a 16 year old female patient. The vaccine expired on 30th June 2025, it was administered on 14th August 2025 which led to expired vaccine used. The reporter asked did the patient need to be revaccinated.